About
Therapeutics harnessing the Integrated Stress Response
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
123
By Phase
PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05508074Lead Sponsor
Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)
PHASE2Completed
51 participants
Started: Dec 2, 2022 · Completed: Jan 20, 2025
NCT03610334Lead Sponsor
A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088
PHASE1Completed
72 participants
Started: Jun 21, 2018 · Completed: Dec 16, 2019
Locations (1)
Headquarters
Nantes, France
Map
Loading map...